The enhanced anti-tumor activity was accompanied by a significantly higher CD8+ T cell infiltration into the tumor and significantly increased numbers of tumor-antigen-positive OVA-specific CD8+ T cells as well as IFN-γ secreting cells in the tumor draining lymph node. This evidence concerns the gene CD8A and neoplasm.